CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 10 | −11 |
| Shares | 1.30M | 139.4K | −1.16M (−89.3%) |
| Value | $232.0K | $335.0K | +$103.0K (+44.4%) |
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 133,229 | $319.8K | 0.01% |
| UBS Group AG | 1,213 | $2.91K | 0.00% |
| The PNC Financial Services Group, Inc. | 8 | $20 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1 | $2 | 0.00% |
Sold out (15)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Vanguard Group Inc | 453,615 | $81.0K |
| Bank of New York Mellon Corp | 203,548 | $36.0K |
| Geode Capital Management, LLC | 129,016 | $23.0K |
| Virtu Financial LLC | 127,922 | $23.0K |
| Two Sigma Securities, LLC | 90,487 | $16.0K |
| Renaissance Technologies LLC | 56,800 | $10.0K |
| FSM Wealth Advisors, LLC | 40,000 | $7.00K |
| Northern Trust Corp | 32,094 | $6.00K |
| Cambridge Investment Research Advisors, Inc. | 25,250 | $5.00K |
| State Street Corp | 19,645 | $4.00K |
| Commonwealth Equity Services, LLC | 20,000 | $3.00K |
| Goldman Sachs Group Inc | 18,549 | $3.00K |
| HighTower Advisors, LLC | 18,000 | $3.00K |
| Alpha Cubed Investments, LLC | 10,000 | $2.00K |
| Prime Capital Investment Advisors, LLC | 10,727 | $2.00K |